BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27510266)

  • 21. Tissue-specific FAH deficiency alters sleep-wake patterns and results in chronic tyrosinemia in mice.
    Yang S; Siepka SM; Cox KH; Kumar V; de Groot M; Chelliah Y; Chen J; Tu B; Takahashi JS
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22229-22236. PubMed ID: 31611405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant.
    Ibarra-González I; Fernández-Lainez C; Alcántara-Ortigoza MA; González-Del Angel A; Fernández-Henández L; Guillén-López S; Belmont-Martínez L; López-Mejía L; Varela-Fascinetto G; Vela-Amieva M
    Mol Genet Genomic Med; 2019 Dec; 7(12):e937. PubMed ID: 31568711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xeno-repopulation of Fah -/- Nod/Scid mice livers by human hepatocytes.
    Su B; Liu C; Xiang D; Zhang H; Yuan S; Wang M; Chen F; Zhu H; He Z; Wang X; Hu Y
    Sci China Life Sci; 2011 Mar; 54(3):227-34. PubMed ID: 21416322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery.
    Held PK; Olivares EC; Aguilar CP; Finegold M; Calos MP; Grompe M
    Mol Ther; 2005 Mar; 11(3):399-408. PubMed ID: 15727936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress.
    Dieter MZ; Freshwater SL; Miller ML; Shertzer HG; Dalton TP; Nebert DW
    Free Radic Biol Med; 2003 Aug; 35(4):351-67. PubMed ID: 12899938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease.
    Hickey RD; Mao SA; Glorioso J; Lillegard JB; Fisher JE; Amiot B; Rinaldo P; Harding CO; Marler R; Finegold MJ; Grompe M; Nyberg SL
    Stem Cell Res; 2014 Jul; 13(1):144-53. PubMed ID: 24879068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model.
    Orejuela D; Jorquera R; Bergeron A; Finegold MJ; Tanguay RM
    J Hepatol; 2008 Feb; 48(2):308-17. PubMed ID: 18093685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic liver reconstitution with murine cells isolated long after death.
    Erker L; Azuma H; Lee AY; Guo C; Orloff S; Eaton L; Benedetti E; Jensen B; Finegold M; Willenbring H; Grompe M
    Gastroenterology; 2010 Sep; 139(3):1019-29. PubMed ID: 20621682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development.
    Marhenke S; Lamlé J; Buitrago-Molina LE; Cañón JM; Geffers R; Finegold M; Sporn M; Yamamoto M; Manns MP; Grompe M; Vogel A
    Hepatology; 2008 Aug; 48(2):487-96. PubMed ID: 18666252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.
    Eggenhofer E; Doenecke A; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
    J Gastroenterol Hepatol; 2010 May; 25(5):1002-8. PubMed ID: 20546455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.
    Overturf K; al-Dhalimy M; Ou CN; Finegold M; Tanguay R; Lieber A; Kay M; Grompe M
    Hum Gene Ther; 1997 Mar; 8(5):513-21. PubMed ID: 9095403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death.
    Vogel A; van Den Berg IE; Al-Dhalimy M; Groopman J; Ou CN; Ryabinina O; Iordanov MS; Finegold M; Grompe M
    Hepatology; 2004 Feb; 39(2):433-43. PubMed ID: 14767996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I.
    Li N; Gou S; Wang J; Zhang Q; Huang X; Xie J; Li L; Jin Q; Ouyang Z; Chen F; Ge W; Shi H; Liang Y; Zhuang Z; Zhao X; Lian M; Ye Y; Quan L; Wu H; Lai L; Wang K
    Mol Ther; 2021 Mar; 29(3):1001-1015. PubMed ID: 33221434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia.
    Demers SI; Russo P; Lettre F; Tanguay RM
    Hum Pathol; 2003 Dec; 34(12):1313-20. PubMed ID: 14691918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fah Knockout Animals as Models for Therapeutic Liver Repopulation.
    Grompe M
    Adv Exp Med Biol; 2017; 959():215-230. PubMed ID: 28755199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I.
    Balestra D; Scalet D; Ferrarese M; Lombardi S; Ziliotto N; C Croes C; Petersen N; Bosma P; Riccardi F; Pagani F; Pinotti M; van de Graaf SFJ
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer.
    Hickey RD; Lillegard JB; Fisher JE; McKenzie TJ; Hofherr SE; Finegold MJ; Nyberg SL; Grompe M
    Hepatology; 2011 Oct; 54(4):1351-9. PubMed ID: 21674562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
    Yin H; Xue W; Chen S; Bogorad RL; Benedetti E; Grompe M; Koteliansky V; Sharp PA; Jacks T; Anderson DG
    Nat Biotechnol; 2014 Jun; 32(6):551-3. PubMed ID: 24681508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions.
    Nicolas CT; VanLith CJ; Hickey RD; Du Z; Hillin LG; Guthman RM; Cao WJ; Haugo B; Lillegard A; Roy D; Bhagwate A; O'Brien D; Kocher JP; Kaiser RA; Russell SJ; Lillegard JB
    Nat Commun; 2022 Aug; 13(1):5012. PubMed ID: 36008405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Animal models of tyrosinemia.
    Nakamura K; Tanaka Y; Mitsubuchi H; Endo F
    J Nutr; 2007 Jun; 137(6 Suppl 1):1556S-1560S; discussion 1573S-1575S. PubMed ID: 17513424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.